000			02039nam a22001697a 4500
001			CUHAS/BP/ 3000500/T/17
008			211210b |||||||| |||| 00| 0 eng d
100			_a Eugen R Kimaro _dCUHAS/BP/ 3000500/T/17 _926692 _eUndergraduate Ethical Clearance Certificate No. 1864/2021
245			_aRisk Factors and Management of Peripheral Neuropathy Among Pediatric Cancer Patients at Bugando Medical Centre, Oncology Unit
260			_aMwanza, Tanzania: _b Catholic University of Health and Allied Sciences [CUHAS - Bugando] : _bPhone: +255 28 298 3384 : _b Fax: +255 28 298 3386 : _b Email: vc@bugando.ac.tz : _b Website: www.bugando.ac.tz : _c ©14.09.2021
300			_axi; 24 Pages
300			_aIncludes References and Appendices
520			_aAbstract: Peripheral neuropathy is among the complications that occur in cancer patients. Several risk factors are associated with the development of peripheral neuropathy, these include infectious diseases such as HIV infection, hereditary diseases such as diabetes, patients’ factors such as age, exposure to smoking or alcohol and chemotherapeutic agents such as cisplatin and vincristine. This study aimed to providing information on the prevalence, risk factors and management of peripheral neuropathy among paediatric cancer patients. It was a retrospective cross-sectional study among Paediatrics admitted in the Oncology Unit at Bugando Medical Centre from January 2018 to December 2020 using convenience sampling. The prevalence of peripheral neuropathy was 2.3% among the 384 patients reviewed. Reducing doses and postponing chemotherapy is among the intervention methods used. However, management of peripheral neuropathy was not well documented in more than half of the diagnosed patients at Bugando Medical Centre. The present study has shown a significant low prevalence of peripheral neuropathy among paediatric cancer with inadequate records of management.
610			_xPharmacology _926694
700			_aKarol Marwa _919607
942			_2ddc _cCR
999			_c22196 _d22196